Loading...
Loading...
Among the 3 tracked institutional investors we monitor, ERNA (ERNEXA THERAPEUTICS INC) is held with a combined value of $49.85K across 69,818 shares. The largest holder is VANGUARD GROUP INC with a position worth $43.11K (0.00% of their portfolio). 2 funds opened new positions in the most recent quarter.
Total Institutional Value
$49.85K
Total Shares Held
69,818
Institutional Holders
3
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $43.11K | 0.00% | New |
| 2 | CITADEL ADVISORS LLC | $6.58K | 0.00% | New |
| 3 | BlackRock, Inc. | $163 | 0.00% | - |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of ERNA with a position worth $43.11K, representing 0.00% of their portfolio. In total, 3 institutional investors hold ERNA with a combined value of $49.85K.
In the most recent quarter, 2 funds opened a new position in ERNA.
Institutional investors hold $49.85K worth of ERNA stock across 3 positions. The largest institutional holder is VANGUARD GROUP INC with $43.11K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For ERNA, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their ERNA positions.